2024-12-012025-11-302025-11-30false11689155WORLD EYE VISION LTD.2026-08-2896090falseiso4217:GBPxbrli:pure116891552024-11-30116891552025-11-30116891552024-12-012025-11-30116891552023-11-30116891552024-11-30116891552023-12-012024-11-3011689155bus:SmallEntities2024-12-012025-11-3011689155bus:AuditExempt-NoAccountantsReport2024-12-012025-11-3011689155bus:FullAccounts2024-12-012025-11-3011689155bus:PrivateLimitedCompanyLtd2024-12-012025-11-3011689155core:WithinOneYear2025-11-3011689155core:AfterOneYear2025-11-3011689155core:WithinOneYear2024-11-3011689155core:AfterOneYear2024-11-3011689155core:ShareCapital2025-11-3011689155core:SharePremium2025-11-3011689155core:RevaluationReserve2025-11-3011689155core:OtherReservesSubtotal2025-11-3011689155core:RetainedEarningsAccumulatedLosses2025-11-3011689155core:ShareCapital2024-11-3011689155core:SharePremium2024-11-3011689155core:RevaluationReserve2024-11-3011689155core:OtherReservesSubtotal2024-11-3011689155core:RetainedEarningsAccumulatedLosses2024-11-3011689155core:LandBuildings2025-11-3011689155core:PlantMachinery2025-11-3011689155core:Vehicles2025-11-3011689155core:FurnitureFittings2025-11-3011689155core:OfficeEquipment2025-11-3011689155core:NetGoodwill2025-11-3011689155core:IntangibleAssetsOtherThanGoodwill2025-11-3011689155core:ListedExchangeTraded2025-11-3011689155core:UnlistedNon-exchangeTraded2025-11-3011689155core:LandBuildings2024-11-3011689155core:PlantMachinery2024-11-3011689155core:Vehicles2024-11-3011689155core:FurnitureFittings2024-11-3011689155core:OfficeEquipment2024-11-3011689155core:NetGoodwill2024-11-3011689155core:IntangibleAssetsOtherThanGoodwill2024-11-3011689155core:ListedExchangeTraded2024-11-3011689155core:UnlistedNon-exchangeTraded2024-11-3011689155core:LandBuildings2024-12-012025-11-3011689155core:PlantMachinery2024-12-012025-11-3011689155core:Vehicles2024-12-012025-11-3011689155core:FurnitureFittings2024-12-012025-11-3011689155core:OfficeEquipment2024-12-012025-11-3011689155core:NetGoodwill2024-12-012025-11-3011689155core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3011689155core:ListedExchangeTraded2024-12-012025-11-3011689155core:UnlistedNon-exchangeTraded2024-12-012025-11-3011689155core:MoreThanFiveYears2024-12-012025-11-3011689155core:Non-currentFinancialInstruments2025-11-3011689155core:Non-currentFinancialInstruments2024-11-3011689155dpl:CostSales2024-12-012025-11-3011689155dpl:DistributionCosts2024-12-012025-11-3011689155core:LandBuildings2024-12-012025-11-3011689155core:PlantMachinery2024-12-012025-11-3011689155core:Vehicles2024-12-012025-11-3011689155core:FurnitureFittings2024-12-012025-11-3011689155core:OfficeEquipment2024-12-012025-11-3011689155dpl:AdministrativeExpenses2024-12-012025-11-3011689155core:NetGoodwill2024-12-012025-11-3011689155core:IntangibleAssetsOtherThanGoodwill2024-12-012025-11-3011689155dpl:GroupUndertakings2024-12-012025-11-3011689155dpl:ParticipatingInterests2024-12-012025-11-3011689155dpl:GroupUndertakingscore:ListedExchangeTraded2024-12-012025-11-3011689155core:ListedExchangeTraded2024-12-012025-11-3011689155dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-12-012025-11-3011689155core:UnlistedNon-exchangeTraded2024-12-012025-11-3011689155dpl:CostSales2023-12-012024-11-3011689155dpl:DistributionCosts2023-12-012024-11-3011689155core:LandBuildings2023-12-012024-11-3011689155core:PlantMachinery2023-12-012024-11-3011689155core:Vehicles2023-12-012024-11-3011689155core:FurnitureFittings2023-12-012024-11-3011689155core:OfficeEquipment2023-12-012024-11-3011689155dpl:AdministrativeExpenses2023-12-012024-11-3011689155core:NetGoodwill2023-12-012024-11-3011689155core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3011689155dpl:GroupUndertakings2023-12-012024-11-3011689155dpl:ParticipatingInterests2023-12-012024-11-3011689155dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3011689155core:ListedExchangeTraded2023-12-012024-11-3011689155dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3011689155core:UnlistedNon-exchangeTraded2023-12-012024-11-3011689155core:NetGoodwill2025-11-3011689155core:IntangibleAssetsOtherThanGoodwill2025-11-3011689155core:LandBuildings2025-11-3011689155core:PlantMachinery2025-11-3011689155core:Vehicles2025-11-3011689155core:FurnitureFittings2025-11-3011689155core:OfficeEquipment2025-11-3011689155core:AfterOneYear2025-11-3011689155core:WithinOneYear2025-11-3011689155core:ListedExchangeTraded2025-11-3011689155core:UnlistedNon-exchangeTraded2025-11-3011689155core:ShareCapital2025-11-3011689155core:SharePremium2025-11-3011689155core:RevaluationReserve2025-11-3011689155core:OtherReservesSubtotal2025-11-3011689155core:RetainedEarningsAccumulatedLosses2025-11-3011689155core:NetGoodwill2024-11-3011689155core:IntangibleAssetsOtherThanGoodwill2024-11-3011689155core:LandBuildings2024-11-3011689155core:PlantMachinery2024-11-3011689155core:Vehicles2024-11-3011689155core:FurnitureFittings2024-11-3011689155core:OfficeEquipment2024-11-3011689155core:AfterOneYear2024-11-3011689155core:WithinOneYear2024-11-3011689155core:ListedExchangeTraded2024-11-3011689155core:UnlistedNon-exchangeTraded2024-11-3011689155core:ShareCapital2024-11-3011689155core:SharePremium2024-11-3011689155core:RevaluationReserve2024-11-3011689155core:OtherReservesSubtotal2024-11-3011689155core:RetainedEarningsAccumulatedLosses2024-11-3011689155core:NetGoodwill2023-11-3011689155core:IntangibleAssetsOtherThanGoodwill2023-11-3011689155core:LandBuildings2023-11-3011689155core:PlantMachinery2023-11-3011689155core:Vehicles2023-11-3011689155core:FurnitureFittings2023-11-3011689155core:OfficeEquipment2023-11-3011689155core:AfterOneYear2023-11-3011689155core:WithinOneYear2023-11-3011689155core:ListedExchangeTraded2023-11-3011689155core:UnlistedNon-exchangeTraded2023-11-3011689155core:ShareCapital2023-11-3011689155core:SharePremium2023-11-3011689155core:RevaluationReserve2023-11-3011689155core:OtherReservesSubtotal2023-11-3011689155core:RetainedEarningsAccumulatedLosses2023-11-3011689155core:AfterOneYear2024-12-012025-11-3011689155core:WithinOneYear2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:CostValuation2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-012025-11-3011689155core:Non-currentFinancialInstrumentscore:CostValuation2025-11-3011689155core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-11-3011689155core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3011689155core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3011689155core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3011689155core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3011689155core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3011689155core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3011689155core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3011689155core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3011689155core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3011689155bus:Director12024-12-012025-11-3011689155bus:Director22024-12-012025-11-30

WORLD EYE VISION LTD.

Registered Number
11689155
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2025

WORLD EYE VISION LTD.
Company Information
for the year from 1 December 2024 to 30 November 2025

Directors

Farrukh KHAN
NALLAPPANE, Vimal

Registered Address

6 - 9 The Square
Stockley Park
Uxbridge
UB11 1FW

Registered Number

11689155 (England and Wales)
WORLD EYE VISION LTD.
Balance Sheet as at
30 November 2025

Notes

2025

2024

£

£

£

£

Current assets
Stocks370,45159,136
Debtors4829,151640,428
Cash at bank and on hand139,36619,094
1,038,968718,658
Creditors amounts falling due within one year5(540,427)(312,101)
Net current assets (liabilities)498,541406,557
Total assets less current liabilities498,541406,557
Net assets498,541406,557
Capital and reserves
Called up share capital11
Profit and loss account498,540406,556
Shareholders' funds498,541406,557
The financial statements were approved and authorised for issue by the Board of Directors on 28 August 2026, and are signed on its behalf by:
Farrukh KHAN
Director
Registered Company No. 11689155
WORLD EYE VISION LTD.
Notes to the Financial Statements
for the year ended 30 November 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Related parties
The company is controlled by Farrukh Khan, its sole shareholder and a director. The following are related parties by virtue of his interests in them: American Eye Vision Inc., a company incorporated in the United States of which he is Chief Operating Officer; Visiontech Export International (Pvt) Ltd, in which he holds 50 per cent; and Pinnacle Enterprise, a partnership in which he holds a 50 per cent share. During the year the company made purchases from these entities of £1,311,400 (2024: £906,400). All transactions were conducted on normal commercial terms. At the year end the company was owed £828,472 (2024: £639,748) by American Eye Vision Inc., representing the net proceeds of sales collected from the company's customers after payment of the company's suppliers. Amounts owed by the company to related parties were £222,229 (2024: £111,610), comprising American Eye Vision Inc. £109,425, Visiontech Export International (Pvt) Ltd £63,654 and Pinnacle Enterprise £49,150.
2.Average number of employees

20252024
Average number of employees during the year21
3.Stocks

2025

2024

££
Finished goods70,45159,136
Total70,45159,136
4.Debtors: amounts due within one year

2025

2024

££
Other debtors829,151640,428
Total829,151640,428
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables380,967189,017
Amounts owed to related parties936624
Taxation and social security114,410112,064
Other creditors5,3386,510
Accrued liabilities and deferred income38,7763,886
Total540,427312,101
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.